Antibiotic for liver disease linked to emergence of antimicrobial resistant superbug
An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form of the antimicrobial…
Read More...
Read More...